Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 22 citing articles:

Potential inhibitory effect of Auricularia auricula polysaccharide on advanced glycation end-products (AGEs)
Pin Gong, Shuya Pei, Hui Long, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 129856-129856
Closed Access | Times Cited: 20
Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists
Puja Ghosh, Rosaria Anna Fontanella, Lucia Scisciola, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 4872-4884
Open Access | Times Cited: 24
NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook
Alberto Nascè, Karim Gariani, François R. Jornayvaz, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1131-1131
Open Access | Times Cited: 28
The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD
Ana G. Petrovic, Dunja Igrec, Karla Rožac, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 4544-4556
Open Access | Times Cited: 22
Semaglutide 6-months therapy of type 2 diabetes mellitus restores adipose progenitors potential to develop metabolically active adipocytes
Iurii Stafeev, Margarita Agareva, Svetlana Michurina, et al.
European Journal of Pharmacology (2024) Vol. 970, pp. 176476-176476
Closed Access | Times Cited: 7
Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease
Cheng Zhu, Qian Huai, Xu Zhang, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 1, pp. 311-330
Open Access | Times Cited: 26
Pure total flavonoids from citrus alleviate oxidative stress and inflammation in nonalcoholic fatty liver disease by regulating the miR-137-3p/NOXA2/NOX2 pathway
Junbin Yan, Yunmeng Nie, Sumei Xu, et al.
Phytomedicine (2023) Vol. 118, pp. 154944-154944
Closed Access | Times Cited: 16
Implications of receptor for advanced glycation end products for progression from obesity to diabetes and from diabetes to cancer
Andrea Garza-Campos, José Roberto Prieto-Correa, José Alfredo Domínguez‐Rosales, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 7, pp. 977-994
Open Access | Times Cited: 11
Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD
Manuela Vitulo, Elisa Gnodi, Giulia Rosini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12748-12748
Open Access | Times Cited: 11
Liraglutide, a glucagon-like peptide-1 receptor agonist, ameliorates inflammation and apoptosis via inhibition of receptor for advanced glycation end products signaling in AGEs induced chondrocytes
Xianyu Zhang, Jian Jiang, Jiajia Xu, et al.
BMC Musculoskeletal Disorders (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Nicotinamide Adenine Dinucleotide Phosphate Oxidases and Metabolic Dysfunction-Associated Steatotic Liver Disease
Vittoria Cammisotto, Emanuele Valeriani, Pasquale Pignatelli, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 83-83
Open Access
Liraglutide inhibits the proliferation of rat hepatic stellate cells under high glucose conditions by suppressing the ERK signaling pathway
Bingge Fan, Ling‐bing Meng, Xiao Zheng, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The Expanding Role of GLP-1 Receptor Agonists: Advancing Clinical Outcomes in Metabolic and Mental Health
Mohamad Al Qassab, M.A. Mneimneh, Ahmad Jradi, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 285-285
Open Access
Animal studies on glucagon-like peptide-1 receptor agonists and related polyagonists in nonalcoholic fatty liver disease
Chara Tsiampali, Ilias D. Vachliotis, A. Goulas, et al.
HORMONES (2024) Vol. 23, Iss. 4, pp. 611-619
Open Access | Times Cited: 3
Quantitative Assessment of Intracellular Effectors and Cellular Response in RAGE Activation
Vinitha Deepu, Vikrant Rai, Devendra K Agrawal
Archives of Internal Medicine Research (2024) Vol. 07, Iss. 02
Open Access | Times Cited: 3
Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations
Panagiotis Theofilis, Aikaterini Vordoni, Rigas Kalaitzidis
World Journal of Gastroenterology (2022) Vol. 28, Iss. 39, pp. 5691-5706
Open Access | Times Cited: 14
Liraglutide Attenuates Hepatic Oxidative Stress, Inflammation, and Apoptosis in Streptozotocin-Induced Diabetic Mice by Modulating the Wnt/β-Catenin Signaling Pathway
Jie Yu, Yuan Zhao, Lingling Xu, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-12
Open Access | Times Cited: 7
A standardized pomegranate fruit extract ameliorates thioacetamide-induced liver fibrosis in rats via AGE-RAGE-ROS signaling
Hadeer M. Abouelezz, George S.G. Shehatou, Abdelhadi M. Shebl, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e14256-e14256
Open Access | Times Cited: 7
Liraglutide With Metformin Therapy Ameliorates Hepatic Steatosis and Liver Injury in a Mouse Model of Non-alcoholic Steatohepatitis
Hong‐Yi Chiu, Shih‐Chang Tsai, Fuu‐Jen Tsai, et al.
In Vivo (2023) Vol. 37, Iss. 3, pp. 1037-1046
Open Access | Times Cited: 6
Comprehensive research on the properties of advanced glycation end products in food and biological samples and their harmful role in inducing metabolic diseases
Min Ji Gu, Yu Ra Lee, Donghwan Kim, et al.
Comprehensive Reviews in Food Science and Food Safety (2024) Vol. 23, Iss. 5
Open Access | Times Cited: 2
Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis
Tea Omanović Kolarić, Tomislav Kizivat, Vjera Mihaljević, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 8, pp. 3465-3480
Open Access | Times Cited: 8
Oxymatrine relieves non-alcoholic fatty liver disease by promoting the sirtuin 1/adenosine 5‘-monophosphate-activated protein kinase pathway and peroxisome proliferator activated receptor alpha-mediated hepatic fatty acid oxidation
Yijun Wu, Jingfang Xiong, Gao‐Feng Chen, et al.
European Journal of Pharmacology (2024), pp. 177173-177173
Closed Access
Effect of Empagliflozin On Liver Enzymes of Patients In Non-Alcoholic Steatohepatitis In Type 2 Diabetes Mellitus
Nauman Wazir, Shafqat Rehman, Muhammad Nadeem Arshad, et al.
Journal of Gandhara Medical and Dental Science (2023) Vol. 10, Iss. 2, pp. 30-33
Open Access
Oxidative Medicine and Novel Pharmacological Treatment Approaches in Liver Disease
Dinesh Mani Tripathi, Priyansha Singh, Akash Kumar Mourya, et al.
(2023), pp. 281-303
Closed Access
Page 1

Scroll to top